Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Clem

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
South Dakota Journal of Medicine|November 9, 2002
Hormone replacement therapy: the debate beginsJames R Clem
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 19, 2011
Atrial fibrillation treatment updateJames R Clem
South Dakota Medicine : the Journal of the South Dakota State Medical Association|June 3, 2008
Warfarin dosing and genetic testingJames R Clem
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 27, 2010
Dronedarone: where does it fit in the treatment of atrial fibrillation?James R Clem
South Dakota Medicine : the Journal of the South Dakota State Medical Association|July 11, 2006
Anti-factor Xa levels: when should they be used?James R Clem
South Dakota Journal of Medicine|July 16, 2004
Performance enhancement drugs: safe and effective?James R Clem
South Dakota Medicine : the Journal of the South Dakota State Medical Association|November 28, 2013
Management of hot flashes in menopausal womenLaura Johnson, James R Clem
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 17, 2017
Evolving Pharmacologic Therapies for Heart FailureJames R Clem, Jodi Heins
Clinical Pharmacology : Advances and Applications|February 1, 2012
A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapyJoe D Strain, Debra K Farver, James R Clem
Risk Management and Healthcare Policy|February 8, 2012
Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?James R Clem, Joe D Strain, Debra K Farver
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
South Dakota Journal of Medicine|November 9, 2002
Hormone replacement therapy: the debate beginsJames R Clem
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 19, 2011
Atrial fibrillation treatment updateJames R Clem
South Dakota Medicine : the Journal of the South Dakota State Medical Association|June 3, 2008
Warfarin dosing and genetic testingJames R Clem
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 27, 2010
Dronedarone: where does it fit in the treatment of atrial fibrillation?James R Clem
South Dakota Medicine : the Journal of the South Dakota State Medical Association|July 11, 2006
Anti-factor Xa levels: when should they be used?James R Clem
South Dakota Journal of Medicine|July 16, 2004
Performance enhancement drugs: safe and effective?James R Clem
South Dakota Medicine : the Journal of the South Dakota State Medical Association|November 28, 2013
Management of hot flashes in menopausal womenLaura Johnson, James R Clem
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 17, 2017
Evolving Pharmacologic Therapies for Heart FailureJames R Clem, Jodi Heins
Clinical Pharmacology : Advances and Applications|February 1, 2012
A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapyJoe D Strain, Debra K Farver, James R Clem
Risk Management and Healthcare Policy|February 8, 2012
Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?James R Clem, Joe D Strain, Debra K Farver
Pageof 2